Using innovative new tools to advance progress in NTDs (Page)
https://www.swisstph.ch/en/impact-stories/using-innovative-new-tools-to-advance-progress-in-ntds
Innovation has enabled unprecedented progress in the fight against neglected tropical diseases (NTDs). There has also been a fundamental shift from the traditional approach of treating individual pati
FAQ (Page)
https://www.swisstph.ch/en/topics/non-communicable-diseases/physical-activity/sophya/faq
Häufige Fragen zur SOPHYA-Studie 1. Um was geht es in dieser Studie? Sport und Bewegung leisten einen wichtigen Beitrag zur Gesundheitsförderung und Entwicklung im Kindes und Jugendalter. Um Massnahme
SOPHYA I (Page)
https://www.swisstph.ch/en/topics/non-communicable-diseases/physical-activity/sophya/sophya-i
SOPHYA: Swiss children’s Objectively measured PHYsical Activity Lo studio SOPHYA ha analizzato il modo in cui i bambini e gli adolescenti di tutta la Svizzera si muovono o praticano sport e come quest
Science of Eradication: Malaria (Courses)
The Science of Eradication: Malaria Core Course is an intensive weeklong foundational leadership development course that provides participants with a multidisciplinary perspective on approaches to mal
Malaria eradication requires more than magic bullets (Blog)
https://www.swisstph.ch/en/impact-stories/malaria-eradication-requires-more-than-magic-bullets/blog-id/39
The global community has made impressive strides in malaria control and elimination, but progress has stalled. To reach eradication, we must rethink our approach.
Warum wir uns mit der Einschätzung von Risiken so schwertun (Blog)
https://www.swisstph.ch/en/impact-stories/warum-wir-uns-mit-der-einschaetzung-von-risiken-so-schwertun/blog-id/38
Egal ob bei tödlichen Krankheiten, radioaktiven Gasen oder 5G-Strahlung: intuitiv schätzen wir unser eigenes Risiko häufig falsch ein. Darum braucht es nun neue Ansätze, um Risiken effektiv zu kommuni
Pfizer-Preis geht an zwei Swiss TPH Forscher (Page)
https://www.swisstph.ch/en/news/20190207-pfizer-preis-2
Pfizer-Preis geht an zwei Swiss TPH Forscher 07.02.2019 Kristina Keitel-Hasler und Niklaus Labhardt, beide Forscher in der Clinical Research Unit am Swiss TPH, erhalten den Pfizer Forschungspreis 2019